NCT04870034 Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer Status WITHDRAWN Phase EARLY_PHASE1
NCT04802876 Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04682431 A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04625647 Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04554875 Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules Status UNKNOWN Phase N/A
NCT04339218 Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma Status RECRUITING Phase PHASE3
NCT04119024 Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT03905317 Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene Status UNKNOWN Phase PHASE2
NCT03904563 Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma Status COMPLETED Phase PHASE2
NCT03891173 A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma Status TERMINATED Phase PHASE2
NCT03704870 Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection Status COMPLETED Phase PHASE2
NCT03544814 EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression Status COMPLETED Phase PHASE2
NCT03486496 Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation Status UNKNOWN Phase PHASE2
NCT03391869 Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3